‘Innovation in PPI’ Soapbox
Dementia ResearcherHave you got a novel idea about how to approach PPI in research? Prepared to pitch it on our PPI Soapbox?
Dissemination
“Staying safe” – a narrative review of falls prevention in people with Parkinson’s – “PDSAFE”
Parkinson’s disease demonstrates a spectrum of motor and non-motor symptoms. Falling is common and disabling.
#NHSWonderWomen
Adam SmithShowcasing the talent of North West women in health and social care research
£1.2 million to roll-out dementia care home programme to COVID-hit sector
New government funding to help researchers develop an innovative online programme to improve and personalise care for people with dementia in care homes, which were hard-hit by the COVID-19 crisis.
10,000 research participants recruited through Join Dementia Research – Could it help your study?
Could Join Dementia Research help recruit to your study? Meeting those essential targets
2019 – A Year of Hope for Alzheimer’s Research
Alz ForumIn the year just past, Alzheimer’s researchers, families, and stakeholders felt renewed hope that new treatments might be within grasp. This update from the Alz Forum summarises how some of the increased funding might be spent.
2019 Alzheimer’s Society Dementia Research Leaders award winners announced
The winners of the Alzheimer’s Society ‘Dementia Research Leaders awards’ were announced at our annual conference.
40 Must-read academic blogs for researchers and PhD students
40 popular blogs by academics (who also make the most of Twitter)
6 Highlights from the 2022 ARUK Conference
Alzheimer's Research UKAlzheimer’s Research UK’s annual conference showcased the latest dementia research findings, check out the highlights in this post.
9 in 10 of the public underestimate the impact of dementia
A public opinion poll conducted by YouGov for EMBED-Care, finds that only 42% of the British public are aware that dementia is a terminal illness
A brief history of research impact: how has impact assessment evolved in the UK and Australia?
Kate Williams and Jonathan Grant document the evolution of research impact assessment in the UK and Australia.
A Clinical & Scientific perspective on Lecanemab – UKDRI
UK DRICatch-up on the UKDRI Roundtable to discuss the promising Phase III trial data of lecanemab ollowing presentation of results from Eisai/Biogen at CTAD.